Will biotherapeutics become the new generation of drugs for treating Alzheimer’s disease? And how is this disease linked to inflammation in the brain? Read on here for more….
According to the World Health Organization, a third of the world's population does not have access to essential medicines. Medicines are expensive, not just because they are very costly to develop but because of many additional factors. In this article we discuss the facts behind the scenes and what can be done to make therapeutics more accessible and affordable in developing countries.